Member Info for persimmon

BBC....lol they only tell the truth by mistake.

Regarding the directors remunerations, Steven Williams is a director of 5 companies all allied to Reabold. Does anyone seriously think that he is not pulling monies from each and every one. The longer West Newton is 'dragged out' the better for them. As I have said before W.N must be a success. Any other outcome, like Colter will drag the s.p right down. Is this why they feel that other 'options' should be b(r)ought in? Jim is not an idiot just a realist ! OMO and G.L.

before once

I personally think the results we be categorised as good or very good. My only concern is that the relatively small number of tests will not be sufficient, and the company will be asked to perform more before before mainstream acceptance. Hopefully I will be proved wrong.

isdeer...yes

MasterBaker......One thing is for sure. if West Newton is not a storming success then***********as I headlined earlier is this a distraction for something we don't know but S & S do?. The jury is out for me, until the answer to that question becomes obvious. OMO as always, and DYOR (and there' plenty to do).

Interesting that the Results to December 2019 for Deltic were posted yesterday at Companies House under the name of Cluffs Resources (the name was Deltic until the name change and the directors moved across to Cluffs last month June 2020. Need to do more research on this movement, and why it may have happened. RBD may come good eventually, but for those talking about dividends forget it for the foreseeable future. OMO and G.L to all.

............Whilst time ticks on with W.N.

'Good' read is the 88 page Report of December 2019. Best read a few times though (not with rose coloured glasses on), and always read between the lines. If you do that you will then realise that amongst other indications more dilutions are on the horizon. I hear some say already 'that's ok as long as it's for a good cause'. How many more billions of shares do you want floated in this company? By the way RBD is still an OEIC as far as HMRC are concerned. I will not dwell on Rebold California, I'll let you do that homework. All the best to all invested in here. I hope you do well out of it.

It's easy ....just filter me if you don't want to hear from me. Or is it that deep down you really like to know the other side of the coin even if it make uncomfortable reading. It's called masochism.

BH.....The yolks on you, for not doing your homework !

Coldjoe.....actually got fed up of all the time wasting by S & S so exited; doubled my money mate and sold at 1p. I'm not greedy.

Ruby...If the cap fits wear it !

Doorstop123...very content, keep your eye on it over the next few weeks. I have done more research there than on any other stock (and that's saying something). I did comment on PFD about 3 monts ago and it's up over 250% since. Not bad eh. I will admit in the early days I did make some howlers however. We all do, especially if one listens to the 'wouldn't want to be out of this over the weekend, and it's looking like a ten bagger'.

Just skimmed through results to end of 2019. Oh dear.
Also still recognised as an OEIC by HMRC with all the Vat implications that entails.
Costs in the future due for de-commissioning wells in Cali.
Looks like a very very interesting read for investors. Consult your accountants.
OMO and G.L all

Scriven re 40k....there'e more where that came from too, keep eyes wide open.

IF..."if it's and and's were pots and pans then all the world be tinkers"

At study entry, participants will have an in-person or remote (for example, video) study visit, and will receive a study kit (which will include enough pills for the whole course of study treatment) and a diary in which to record symptoms and when study medications are taken. Participants will provide medical and medication histories, contact information, complete the first day of their symptom and medication diary, and take their first dose of study treatment.
Study staff will contact participants by phone on Days 2, 4, 6, 9, 13, and 17, and at 3 and 6 months after they enter the study. At each visit, participants will be asked how they have been feeling healthwise, review their symptoms and treatment, and record any hospitalizations or urgent visits to emergency rooms or clinics. Participants will return their symptom diary by mail or in person on Day 20. At select sites, participants will have the option of having a blood draw, a nose-throat swab, and a self-collected nose swab at study entry and on Days 6 and 20 (in-person visits).
What treatments or drugs are involved with this study?
Participants will have a 50/50 chance of receiving either active or placebo study treatment, as follows:
Hydroxychloroquine/Placebo two (200 mg each) capsules by mouth twice on the first day, and then one (200 mg) capsule twice a day for 6

"On the other hand, the process of injecting steam, water and other chemicals into wells at high pressure is common, particularly given the heaviness and viscosity of California crude oil. Steam softens the crude, and the pressure pushes it to well bores to be extracted. These high-pressure injections have been put on hold while the state studies the hazards that accompany them".

"Would I want to be out of RBD over the weekend? No sirreee!"

That's the ticket I hear S say to S